Skip to content

Laser Resurfacing Versus Dermabrasion for Scar Revision

A Comparison Evaluation of Fractional Laser Therapy and Dermabrasion for Scar Revision

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01176448
Enrollment
6
Registered
2010-08-06
Start date
2010-04-30
Completion date
2010-09-30
Last updated
2019-11-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cicatrix, Dermabrasion, Coagulation, Laser

Keywords

Cicatrix, Dermabrasion, Coagulation, Laser

Brief summary

Dermabrasion has been the historical standard used for resurfacing scars on the skin. Recently, fractionated laser therapy has been FDA approved for scar resurfacing. This study intends to compare dermabrasion versus fractionated laser therapy for scar resurfacing.

Interventions

DEVICEFractionated laser

Fractionated laser in the form of the Re:Pair CO2 laser manufactured by Solta Medical.

Diamond Fraise Dermabrasion will be performed in standard fashion down to papillary dermis.

Sponsors

University of Minnesota
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Post-surgical or post traumatic scar on face or scalp. * Age 18 or older * Able to read and comprehend English * Willing to follow treatment schedule and post treatment care requirements * Signed the informed consent form * Fitzpatrick skin type I-III

Exclusion criteria

* known photosensitivity * Taken any medications known to induce photosensitivity in previous three months * Taken Accutane within past 12 months * Pregnant or nursing * Currently on topical or oral antibiotics * Immunocompromised status * Skin type IV or greater

Design outcomes

Primary

MeasureTime frameDescription
Safey Data Score Based on Ordinal Ratings of Erythema, Edema, Bleeding, Eschar After ResurfacingDay 0, Week1, Month 1Erythema, edema, bleeding, and eschar after resurfacing were used as indicators of safety. Each was judged based on a 4 point ordinal scale 0=absent, 1=mild, 2=moderate, 3=severe.

Secondary

MeasureTime frameDescription
Visual Analog Scale for Assessing Scar Improvement.3 monthsVisual Analog Scale for assessing scar improvement. 0 : Worsening or no improvement 1. : 1-25% improvement 2. : 26-50% improvement 3. : 51-75% improvement 4. : 76-100% improvement

Countries

United States

Participant flow

Recruitment details

Adult patients aged 18 and older were recruited from a reconstructive surgical practice. Preference was given to patients who had undergone interpolated axial flaps (e.g., forehead flaps) because this allowed treatment of two different scars on a single patient.

Participants by arm

ArmCount
Patients With Scars
12 individual scars on 6 patients were treated. Each scar was divided in half, and the halves randomized to either fractionated laser resurfacing or dermabrasion.
6
Total6

Baseline characteristics

CharacteristicPatients With Scars
Age, Categorical
<=18 years
0 Participants
Age, Categorical
>=65 years
0 Participants
Age, Categorical
Between 18 and 65 years
6 Participants
Age, Continuous54.6 years
STANDARD_DEVIATION 6.5
Region of Enrollment
United States
6 participants
Sex: Female, Male
Female
3 Participants
Sex: Female, Male
Male
3 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
— / —— / —
other
Total, other adverse events
0 / 60 / 6
serious
Total, serious adverse events
0 / 60 / 6

Outcome results

Primary

Safey Data Score Based on Ordinal Ratings of Erythema, Edema, Bleeding, Eschar After Resurfacing

Erythema, edema, bleeding, and eschar after resurfacing were used as indicators of safety. Each was judged based on a 4 point ordinal scale 0=absent, 1=mild, 2=moderate, 3=severe.

Time frame: Day 0, Week1, Month 1

Population: Each scar was divided in half and the halves randomized to either Fractionated Laser treatment or Dermabrasion.

ArmMeasureGroupValue (MEAN)Dispersion
Fractionated LaserSafey Data Score Based on Ordinal Ratings of Erythema, Edema, Bleeding, Eschar After ResurfacingEdema Day 00 units on a scaleStandard Error 0
Fractionated LaserSafey Data Score Based on Ordinal Ratings of Erythema, Edema, Bleeding, Eschar After ResurfacingBleeding Week 10 units on a scaleStandard Error 0
Fractionated LaserSafey Data Score Based on Ordinal Ratings of Erythema, Edema, Bleeding, Eschar After ResurfacingEschar Day 00 units on a scaleStandard Error 0
Fractionated LaserSafey Data Score Based on Ordinal Ratings of Erythema, Edema, Bleeding, Eschar After ResurfacingEschar Week 10.08 units on a scaleStandard Error 0.29
Fractionated LaserSafey Data Score Based on Ordinal Ratings of Erythema, Edema, Bleeding, Eschar After ResurfacingErythema Day 01.33 units on a scaleStandard Error 0.49
Fractionated LaserSafey Data Score Based on Ordinal Ratings of Erythema, Edema, Bleeding, Eschar After ResurfacingErythema Month 10.38 units on a scaleStandard Error 0.52
Fractionated LaserSafey Data Score Based on Ordinal Ratings of Erythema, Edema, Bleeding, Eschar After ResurfacingErythema Week 10.75 units on a scaleStandard Error 0.45
Fractionated LaserSafey Data Score Based on Ordinal Ratings of Erythema, Edema, Bleeding, Eschar After ResurfacingEdema Month 10 units on a scaleStandard Error 0
Fractionated LaserSafey Data Score Based on Ordinal Ratings of Erythema, Edema, Bleeding, Eschar After ResurfacingBleeding Day 01.08 units on a scaleStandard Error 0.29
Fractionated LaserSafey Data Score Based on Ordinal Ratings of Erythema, Edema, Bleeding, Eschar After ResurfacingBleeding Month 10 units on a scaleStandard Error 0
Fractionated LaserSafey Data Score Based on Ordinal Ratings of Erythema, Edema, Bleeding, Eschar After ResurfacingEdema Week 10.17 units on a scaleStandard Error 0.39
Fractionated LaserSafey Data Score Based on Ordinal Ratings of Erythema, Edema, Bleeding, Eschar After ResurfacingEschar Month 10 units on a scaleStandard Error 0
DermabrasionSafey Data Score Based on Ordinal Ratings of Erythema, Edema, Bleeding, Eschar After ResurfacingEdema Week 10.50 units on a scaleStandard Error 0.52
DermabrasionSafey Data Score Based on Ordinal Ratings of Erythema, Edema, Bleeding, Eschar After ResurfacingErythema Day 03.00 units on a scaleStandard Error 0
DermabrasionSafey Data Score Based on Ordinal Ratings of Erythema, Edema, Bleeding, Eschar After ResurfacingEdema Day 00 units on a scaleStandard Error 0
DermabrasionSafey Data Score Based on Ordinal Ratings of Erythema, Edema, Bleeding, Eschar After ResurfacingBleeding Day 02.0 units on a scaleStandard Error 0
DermabrasionSafey Data Score Based on Ordinal Ratings of Erythema, Edema, Bleeding, Eschar After ResurfacingEschar Day 00 units on a scaleStandard Error 0
DermabrasionSafey Data Score Based on Ordinal Ratings of Erythema, Edema, Bleeding, Eschar After ResurfacingErythema Week 11.50 units on a scaleStandard Error 0.52
DermabrasionSafey Data Score Based on Ordinal Ratings of Erythema, Edema, Bleeding, Eschar After ResurfacingEschar Month 10 units on a scaleStandard Error 0
DermabrasionSafey Data Score Based on Ordinal Ratings of Erythema, Edema, Bleeding, Eschar After ResurfacingBleeding Week 10 units on a scaleStandard Error 0
DermabrasionSafey Data Score Based on Ordinal Ratings of Erythema, Edema, Bleeding, Eschar After ResurfacingEschar Week 10.92 units on a scaleStandard Error 0.79
DermabrasionSafey Data Score Based on Ordinal Ratings of Erythema, Edema, Bleeding, Eschar After ResurfacingErythema Month 11.25 units on a scaleStandard Error 1.04
DermabrasionSafey Data Score Based on Ordinal Ratings of Erythema, Edema, Bleeding, Eschar After ResurfacingEdema Month 10 units on a scaleStandard Error 0
DermabrasionSafey Data Score Based on Ordinal Ratings of Erythema, Edema, Bleeding, Eschar After ResurfacingBleeding Month 10 units on a scaleStandard Error 0
Secondary

Visual Analog Scale for Assessing Scar Improvement.

Visual Analog Scale for assessing scar improvement. 0 : Worsening or no improvement 1. : 1-25% improvement 2. : 26-50% improvement 3. : 51-75% improvement 4. : 76-100% improvement

Time frame: 3 months

Population: With 12 pairs of scars gave a 95% probability to detect a treatment difference at a two sided 0.05 significance level if a significant difference between treatments is 1.5 units (based on a 0~-4 scale as mentioned above). This is based on the assumption that the within-patient standard deviation of the response variable is 0.5 units.

ArmMeasureValue (MEAN)Dispersion
Fractionated LaserVisual Analog Scale for Assessing Scar Improvement.1.53 units on a scaleStandard Deviation 0.59
DermabrasionVisual Analog Scale for Assessing Scar Improvement.1.49 units on a scaleStandard Deviation 0.39
Comparison: efficacy outcomes analyzed by 3 surgeons blinded to the treatment and scars evaluated by halves comparing pre-treatment photos to 3-month photos and given a score on the quartile scale described in table 1. The ordinal rater scores of each evaluator were then averaged, and Wilcoxon Signed Ranks performed on the group's scores. (table 5) There were 4 Fraxel winners, 4 Dermabrasion winners, and 4 ties. There was a p value of 0.77 indicating no significant difference between the categoriesp-value: 0.77Wilcoxon (Mann-Whitney)

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026